Modulatory role of neuropeptides in seizures induced in rats by stimulation of glutamate receptors

Journal of Nutrition

Volumn 130, Issue 4 SUPPL., 2000, Pages

  Vezzani, Annamaria ^a   Rizzi, Massimo ^a   Conti, Mirko ^a   Samanin, Rosario ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Epilepsy; Neuropeptide Y; Neuropeptide Y receptors; Rats; Somatostatin; Somatostatin receptors

Indexed keywords

GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; GLUTAMIC ACID DERIVATIVE; KAINIC ACID; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y [13-36]; OCTREOTIDE; PENTETRAZOLE; SEGLITIDE; SOMATOSTATIN; VAPREOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; ENTORHINAL CORTEX; HIPPOCAMPUS; MALE; NERVE EXCITABILITY; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; RAT; SEIZURE; SEIZURE SUSCEPTIBILITY;

ANIMALIA;

EID: 0034063601     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/130.4.1046s     Document Type: Conference Paper

References (29)

1. Boehm, S. & Betz, H. (1997) Somatostatin inhibits excitatory transmission at rat hippocampal synapses via presynaptic receptors. J. Neurosci. 17: 4066-4075.
2. Brooks, P. A., Kelly, J. S., Allen, J. M., Smith, D.A.S. & Stone, T. W. (1987) Direct excitatory effects of neuropeptide Y (NPY) on rat hippocampal neurons in vitro. Brain Res. 408: 295-298.
3. DeLanerolle, N. C., Kim, J. H., Robbins, R. J. & Spencer, D. D. (1989) Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res. 495: 387-395.
4. Epelbaum, J. (1986) Somatostatin in the central nervous system: physiology and pathological modifications. Prog. Neurobiol. 27: 63-100.
5. Fontana, G., De Bernardi, R., Ferro, F., Gemignani, A. & Raiteri, M. (1996) Characterization of the glutamate receptors mediating release of somatostatin from cultured hippocampal neurons. J. Neurochem. 66: 161-168.
6. Gariboldi, M., Conti, M., Cavaleri, D., Samanin, R. & Vezzani, A. (1998) Anticonvulsant properties of BIBP 3226, a non-peptide selective antagonist at neuropeptide Y Y1 receptors. Eur. J. Neurosci. 10: 757-759.
7. Gemignani, A., Marchese, S., Fontana, G. & Raiteri, M. (1997) Neuropeptide Y release from cultured hippocampal neurons: stimulation by glutamate acting at N-methyl-D-aspartate and AMPA receptors. Neuroscience 81: 23-31.
8. Gobbi, M., Monhemius, R., Samanin, R., Mennini, T. & Vezzani, A. (1996) Cellular localization of neuropeptide Y receptors in the rat hippocampus: long-term effects of limbic seizures. NeuroReport 7: 1475-1480.
9. Greber, S., Schwarzer, C. & Sperk, G. (1994) Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. Br. J. Pharmacol. 113: 737-740.
10. Hökfelt, T., Johansson, O., Ljungdahl, A., Lundberg, J. M. & Schultzberg, M. (1980) Peptidergic neurones. Nature (Lond.) 284: 515-521.
11. Hoyer, D., Bell, G. I., Berelowitz, M., Feniuk, W., Humphrey, P.P.A., O'Carroll, A. M. & Patel, Y. C. (1995) Classification and nomenclature of somatostatin receptors. Trends Pharmacol. Sci. 16: 86-88.
12. Klapstein, G. J. & Colmers, W. F. (1993) On the site of presynaptic inhibition by neuropeptide Y in the rat hippocampus in vitro. Hippocampus 3: 103-112.
13. Mancillas, J. R., Siggins, G. R. & Bloom, F. E. (1986) Somatostatin selectively enhances acetylcholine-induced excitations in rat hippocampus and cortex. Proc. Natl. Acad. Sci. U.S.A. 83: 7518-7521.
14. 1 receptors inhibit N-type calcium currents and reduce transient calcium increases in rat dentate granule cells. J. Neurosci. 16: 1422-1429.
15. Michel, M. C., Beck-Sickinger, A., Cox, H., Doods, H. N., Herzog, H., Larhammar, D., Quirion, R., Schwartz, T. & Westfall, T. (1998) XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 50: 143-150.
16. Moore, S. D., Madamba, S. G., Joels, M. & Siggins, G. R. (1988) Somatostatin augments the M-current in hippocampal neurons. Science (Washington, DC) 239: 278-280.
17. Olpe, H. R., Balcar, V. J., Bittiger, H., Rink, H. & Sieber, P. (1980) Central actions of somatostatin. Eur. J. Pharmacol. 63: 127-133.
18. 2 and differential changes in somatostatin receptor messenger RNAs, binding sites and somatostatin release in kainic acid-treated rats. Neuroscience 65: 1087-1097.
19. Piwko, C., Thoss, V. S., Samanin, R., Hoyer, D. & Vezzani, A. (1996) Status of somatostatin receptor messenger RNAs and binding sites in rat brain during kindling epileptogenesis. Neuroscience 75: 857-868.
20. Reubi, J. C. (1985) New specific radioligand for one subpopulation of brain somatostatin receptors. Life Sci. 36: 1829-1836.
21. 1 receptor antagonist: BIBP 3226. Eur. J. Pharmacol. 271: R11-R13.
22. Schwarcz, R. & Meldrum, B. (1985) Excitatory amino acid antagonists provide a therapeutic approach to neurological disorders. Lancet 2: 140-143.
23. Schwarzer, C., Kirchmair, E. & Sperk, G. (1998) Metabotropic receptors mediate activation of NPY-Y2 receptor expression in rat dentate gyrus. Neuro-Report 9: 2347-2351.
24. Schwarzer, C., Sperk, G., Samanin, R., Rizzi, M., Gariboldi, M. & Vezzani, A. (1996) Neuropeptides-immunoreactivity and their mRNA expression in kindling: functional implications for limbic epileptogenesis. Brain Res. Rev. 22: 27-50.
25. Sloviter, R. S. (1991) Permanently altered hippocampal structure, excitability, and inhibition after experimental status epilepticus in the rat: the "dormant basket cell" hypothesis and its possible relevance to temporal lobe epilepsy. Hippocampus 1: 41-66.
26. Sperk, G., Marksteiner, J., Gruber, B., Bellman, R., Mahata, M. & Ortler, M. (1992) Functional changes in neuropeptide Y and somatostatin containing neurons induced by limbic seizures in the rat. Neuroscience 50: 831-846.
27. Vezzani, A., Civenni, G., Rizzi, M., Monno, A., Messali, S. & Samanin, R. (1994) Enhanced neuropeptide Y release in the hippocampus is associated with chronic seizure susceptibility in kainic acid treated rats. Brain Res. 660: 138-143.
28. Vezzani, A., Serafini, R., Stasi, M. A., Vigano, G., Rizzi, M. & Samanin, R. (1991) A peptidase-resistant cyclic octapeptide analogue of somatostatin (SMS 201-995) modulates seizures induced by quinolinic and kainic acids differently in the rat hippocampus. Neuropharmacology 30: 345-352.
29. Vezzani, A., Sperk, G. & Colmers W. F. (1999) Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci. 22: 25-30.